Bellerophon Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
BLPH on OTC
Location
184 Liberty Corner Road, Suite 302, Warren, NJ

There are no Buy or Sell transactions made by insiders since 12/23/2023

Bellerophon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter Fernandes Chief Executive Officer, Principal Financial and Accounting Officer $310K Jun 7, 2023
Martin Dekker VP of Engineering & Manufacturing $155K Jun 7, 2023
Nicholas Laccona Financial Officer, (Pfo & Pao) $155K Feb 10, 2023
Bobae Kim VP Reg. Affairs & Quality $155K Jun 7, 2023
Parag Shah VP of Business Operations $155K Jun 7, 2023
Puissance Life Science Opportunities Fund VI 10%+ Owner $112K Jun 7, 2023
Theodore T. Wang Director $45.3K Jun 7, 2023
Crispin Teufel Director $45.3K Jun 7, 2023
Scott P. Bruder Director $45.3K Jun 7, 2023
Mary Ann Cloyd Director $45.3K Jun 7, 2023
Naseem Amin Director $30.3K Jun 7, 2023
Puissance Capital Management LP 10%+ Owner Oct 13, 2023

Recent Insider Transactions by Companies or Individuals for Bellerophon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.